Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
ANG Lifesciences IPO is a fixed price issue of ₹12.01 crores. The issue is entirely a fresh issue of 0.15 crore shares of ₹12.01 crore.
ANG Lifesciences IPO bidding started from Aug 29, 2017 and ended on Aug 31, 2017. The shares got listed on BSE SME on Sep 8, 2017.
ANG Lifesciences IPO price is ₹80.00 per share . The lot size for an application is 1,600. The minimum amount of investment required by an individual investor (retail) is ₹1,28,000 (1600 shares). The minimum lot size investment for HNI is 2 lots (3,200 shares), amounting to ₹2,56,000.
Oneview Corporate Advisors Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is Guiness Securities Ltd..
Refer to ANG Lifesciences IPO RHP for detailed Information.
| IPO Date | August 29, 2017 to August 31, 2017 |
| Listing Date | September 8, 2017 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹80 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 15,00,800 shares (aggregating up to ₹12.01 Cr) |
| Reserved for Market Maker | 76,800 shares Guiness Securities Ltd. (aggregating up to ₹0.6144 Cr) |
| Net Offered to Public | 14,24,000 shares (aggregating up to ₹11.39 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 36,82,515 shares |
| Share Holding Post Issue | 51,83,315 shares |
ANG Lifesciences IPO offers total 15,00,800 shares. Out of which 7,12,000 (47.44%) allocated to NII, 7,12,000 (47.44%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 76,800 (5.12%) |
| NII (HNI) Shares Offered | 7,12,000 (47.44%) |
| Retail Shares Offered | 7,12,000 (47.44%) |
| Total Shares Offered | 15,00,800 (100.00%) |
ANG Lifesciences IPO opens on August 29, 2017, and closes on August 31, 2017.
| IPO Open Date | Tue, Aug 29, 2017 |
| IPO Close Date | Thu, Aug 31, 2017 |
| Tentative Listing Date | Fri, Sep 8, 2017 |
| Cut-off time for UPI mandate confirmation | 5 PM on Thu, Aug 31, 2017 |
Investors can bid for a minimum of 1,600 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,28,000 |
| Retail (Max) | 1 | 1,600 | ₹1,28,000 |
| HNI (Min) | 2 | 3,200 | ₹2,56,000 |
Incorporated in 2006, ANG Lifesciences India Limited is a pharmaceutical company whose engaged in the business of manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials in India.
Company's products include sterile dry powder vials for anti-biotics, anti-ulcerant, glucocorticoid and anti-inflammatory, anti-malarial, and anesthetic. It manufactures products in compliance with GMP requirements.
However, Company that currently operates at an average capacity utilization of 70% for last two fiscals hopes to achieve 90% plus in coming years. ANGL is likely to consider acquisition options as well to enhance its manufacturing capacities. Its customer list includes Wockhardt, DHS Maharashtra, Global Hospitals, Elder, Emcure, BPPI, Govt. of Haryana, Hetero Healthcare etc.
The Company ANG Lifesciences IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | To meet the working capital requirement | 11.64 |
| 2 | To meet the Issue Expenses | 0.37 |
[Dilip Davda] Investors may consider investment for medium to long term in ANG Lifesciences BSE SME IPO. Read detail review...
| Listing Date | September 8, 2017 |
| BSE Script Code | 540694 |
| NSE Symbol | |
| ISIN | INE236W01016 |
| Final Issue Price | ₹80 per share |
| BSE Listing Group | M |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹80.00 |
| Open | ₹96.00 |
| Low | ₹96.00 |
| High | ₹96.00 |
| Last Trade | ₹96.00 |
ANG Lifesciences India Ltd.
Darbara Complex SCO 113 I Flr,
Dist. Shopping Centre B Block,
Amritsar - 143001
Amritsar, Punjab
Phone: +91-0183-5070118
Email: cs@anglifesciences.com
Website: http://www.anglifesciences.com
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
ANG Lifesciences IPO is a SME IPO of 15,00,800 equity shares of the face value of ₹10 aggregating up to ₹12.01 Crores. The issue is priced at ₹80 per share. The minimum order quantity is 1600.
The IPO opens on August 29, 2017, and closes on August 31, 2017.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in ANG Lifesciences IPO using UPI as a payment gateway. Zerodha customers can apply in ANG Lifesciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in ANG Lifesciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The ANG Lifesciences IPO opens on August 29, 2017 and closes on August 31, 2017.
ANG Lifesciences IPO lot size is 1600, and the minimum amount required for application is ₹1,28,000.
You can apply in ANG Lifesciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for ANG Lifesciences IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the ANG Lifesciences IPO allotment status.
The ANG Lifesciences IPO listing date is on Friday, September 8, 2017.
Useful Articles
RHP